API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
Details:
ODOMZO (sonidegib) works by inhibiting a molecular pathway, known as the hedgehog signaling pathway, which is indicated for the treatment of adult patients with locally advanced basal cell carcinoma.
Lead Product(s): Sonidegib Phosphate
Therapeutic Area: Oncology Product Name: Odomzo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 12, 2020